These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8756669)

  • 1. Stable episomal maintenance of yeast artificial chromosomes in human cells.
    Simpson K; McGuigan A; Huxley C
    Mol Cell Biol; 1996 Sep; 16(9):5117-26. PubMed ID: 8756669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a YAC with human telomeres and oriP from epstein-barr virus in yeast and 293 cells.
    Tolmachova T; Simpson K; Huxley C
    Nucleic Acids Res; 1999 Sep; 27(18):3736-44. PubMed ID: 10471744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A shuttle system for transfer of YACs between yeast and mammalian cells.
    Simpson K; Huxley C
    Nucleic Acids Res; 1996 Dec; 24(23):4693-9. PubMed ID: 8972855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
    Lupton S; Levine AJ
    Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the human CFTR gene from episomal oriP-EBNA1-YACs in mouse cells.
    Huertas D; Howe S; McGuigan A; Huxley C
    Hum Mol Genet; 2000 Mar; 9(4):617-29. PubMed ID: 10699185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication licensing of the EBV oriP minichromosome.
    Hirai K; Shirakata M
    Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A system for shuttling 200-kb BAC/PAC clones into human cells: stable extrachromosomal persistence and long-term ectopic gene activation.
    Westphal EM; Sierakowska H; Livanos E; Kole R; Vos JM
    Hum Gene Ther; 1998 Sep; 9(13):1863-73. PubMed ID: 9741425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Puglielli MT; Woisetschlaeger M; Speck SH
    J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular YAC vectors containing short mammalian origin sequences are maintained under selection as HeLa episomes.
    Nielsen TO; Cossons NH; Zannis-Hadjopoulos M; Price GB
    J Cell Biochem; 2000 Jan; 76(4):674-85. PubMed ID: 10653986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells.
    Wendelburg BJ; Vos JM
    Gene Ther; 1998 Oct; 5(10):1389-99. PubMed ID: 9930345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.
    Leight ER; Sugden B
    Mol Cell Biol; 2001 Jul; 21(13):4149-61. PubMed ID: 11390644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpesvirus papio contains a plasmid origin of replication that acts in cis interspecies with an Epstein-Barr virus trans-acting function.
    Pesano RL; Pagano JS
    J Virol; 1986 Dec; 60(3):1159-62. PubMed ID: 3023667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.
    Sugden B; Warren N
    J Virol; 1989 Jun; 63(6):2644-9. PubMed ID: 2542577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The replisome pausing factor Timeless is required for episomal maintenance of latent Epstein-Barr virus.
    Dheekollu J; Lieberman PM
    J Virol; 2011 Jun; 85(12):5853-63. PubMed ID: 21490103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element.
    Aiyar A; Tyree C; Sugden B
    EMBO J; 1998 Nov; 17(21):6394-403. PubMed ID: 9799247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional limits of oriP, the Epstein-Barr virus plasmid origin of replication.
    Chittenden T; Lupton S; Levine AJ
    J Virol; 1989 Jul; 63(7):3016-25. PubMed ID: 2542609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
    Harrison S; Fisenne K; Hearing J
    J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.